Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: A retrospective study

The Lancet Oncology

Volumn 13, Issue 4, 2012, Pages 366-374

  Fleischhauer, Katharina ^a   Shaw, Bronwen E ^b,c   Gooley, Theodore ^d   Malkki, Mari ^d   Bardy, Peter ^e,f   Bignon, Jean Denis ^g   Dubois, Valérie ^g   Horowitz, Mary M ^h   Madrigal, J Alejandro ^c   Morishima, Yasuo ^j,k   Oudshoorn, Machteld ^l,m   Ringden, Olle ⁿ   Spellman, Stephen ⁱ   Velardi, Andrea ^o   Zino, Elisabetta ^j   Petersdorf, Effie W ^m  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d Fred Hutchinson Cancer Research Center   (United States)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^f ROYAL ADELAIDE HOSPITAL   (Australia)

^g ETABLISSEMENT FRANÇAIS DU SANG   (France)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^j AICHI CANCER CENTER HOSPITAL   (Japan)

^k Japan Marrow Donor Program   (Japan)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m Europdonor Foundation   (Netherlands)

ⁿ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^o UNIVERSITY OF PERUGIA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQB1 ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLELE; ALLOIMMUNITY; ARTICLE; CELL TRANSPLANTATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS REACTION; DISEASE SEVERITY; DONOR; FEMALE; GRAFT RECIPIENT; HEMATOPOIETIC CELL; HEMATOPOIETIC CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EPITOPES, T-LYMPHOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA-DP BETA-CHAINS; HUMANS; RETROSPECTIVE STUDIES; TRANSPLANTATION; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84859161258     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(12)70004-9     Document Type: Article

References (35)

1. Jeng RR, van den Brink MR Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer 2010, 10:221-231.
2. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
3. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010, 11:653-660.
4. Petersdorf EW Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol 2008, 20:588-593.
5. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood 2002, 99:4200-4206.
6. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001, 112:988-994.
7. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007, 110:4560-4566.
8. Shaw BE, Mayor NP, Russell NH, et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010, 24:58-65.
9. Madrigal A, Shaw BE Immunogenetic factors in donors and patients that affect the outcome of hematopoietic stem cell transplantation. Blood Cells Mol Dis 2008, 40:40-43.
10. Gaschet J, Trevino MA, Cherel M, et al. HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease. Blood 1996, 87:2345-2353.
11. Gaschet J, Lim A, Liem L, et al. Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB10501 mismatch. J Clin Invest 1996, 98:100-107.
12. Fleischhauer K, Zino E, Mazzi B, et al. Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DP beta 1-0901. Blood 2001, 98:1122-1126.
13. Cesbron A, Moreau P, Milpied N, Harousseau JL, Muller JY, Bignon JD Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction. Hum Immunol 1992, 33:202-207.
14. Nicholson I, Varney M, Kanaan C, et al. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference. Hum Immunol 1997, 55:163-169.
15. Diaz G, Catalfamo M, Coiras MT, et al. HLA-DPbeta residue 69 plays a crucial role in allorecognition. Tissue Antigens 1998, 52:27-36.
16. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, et al. Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLADPB1 specific immune responses in vitro and in vivo. Blood 2010, 115:151-153.
17. Rutten CE, van Luxemburg-Heijs SA, van der Meijden ED, et al. HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1 specific CD4+ T-cell responses showing immunogenicity of all HLA-DPB1 alleles. Biol Blood Marrow Transpl 2010, 16:1282-1292.
18. Vié H, Gaschet J, Milpied N Permissive, nonpermissive HLA-DPB1 epitope disparities and the specificity of T cells infiltrating the skin during acute graft-versus-host disease. Blood 2011, 117:5779-5781.
19. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004, 103:1417-1424.
20. Fleischhauer K, Locatelli F, Zecca M, et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. Blood 2006, 107:2984-2992.
21. Crocchiolo R, Zino E, Vago L, et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009, 114:1437-1444.
22. Ludajic K, Balavarca Y, Bickeboller H, et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol 2008, 142:436-443.
23. Loiseau P, Busson M, Balere ML, et al. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007, 13:965-974.
24. Morishima Y, Yabet T, Matsuo K, et al. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor. Biol Blood Marrow Transpl 2007, 13:315-328.
25. IMGT/HLA database, (accessed Sept 26, 2011). http://www.ebi.ac.uk/imgt/hla/stats.html.
26. Zino E, Vago L, Di Terlizzi S, et al. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007, 13:1031-1040.
27. Kawase T, Morishima Y, Matsuo K, et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood 2007, 110:2235-2241.
28. Kawase T, Matsuo K, Kashiwase K, et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood 2009, 113:2851-2858.
29. Ferrara GB, Bacigalupo A, Lamparelli T, et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001, 98:3150-3155.
30. Heemskerk MBA, Cornelissen JJ, Roelen DL, et al. Highly diverged MHC class I mismatches are acceptable for hematopoietic stem cell transplantation. Bone Marrow Transpl 2007, 40:193-200.
31. Hogquist KA, Baldwin TA, Jameson SC Central Tolerance: Learning self-control in the thymus. Nat Rev Immunol 2005, 5:772-782.
32. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. New Engl J Med 1990, 323:1818-1822.
33. + T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities. Blood 2010, 116:1991-1992.
34. Kawano M, Kuramoto A, Hirano T, Kishimoto T Cytokines as autocrine growth factors in malignancies. Cancer Surv 1989, 8:905-919.
35. Rutten CE, van Luxemburg-Heijs SA, Griffioen M, et al. HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia. Leukemia 2008, 22:1387-1394.